VATE INNOVATE CORP

INNOVATE Corp. to Report Third Quarter 2024 Results on November 6th

INNOVATE Corp. to Report Third Quarter 2024 Results on November 6th

NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the third quarter 2024 on Wednesday, November 6, 2024, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET.

Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE’s Investor Relations website at . To listen to the live call, please go to the “Investor Relations” section of the Company’s website at least 15 minutes prior to the start of the call to register and download any necessary audio software. For those who are not able to listen to the live broadcast, a replay will be available shortly after the call on the “Investor Relations” portion of the INNOVATE website.

Conference Call Details

Live Call

Domestic Dial-In: 1-800-717-1738

Toll/International: 1-646-307-1865

Conference Replay*

Domestic Dial-In: 1-844-512-2921

Toll/International: 1-412-317-6671

Conference Number: 1192054

*Available approximately three hours after the end of the conference call through November 20, 2024.

About INNOVATE

INNOVATE Corp. is a portfolio of best-in-class assets in three key areas of the new economy – Infrastructure, Life Sciences and Spectrum. Dedicated to stakeholder capitalism, INNOVATE employs approximately 4,000 people across its subsidiaries. For more information, please visit: .

Investor Contact:

Solebury Strategic Communications

Anthony Rozmus



(212) 235-2691



EN
16/10/2024

Underlying

VATEINNOVATE CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on INNOVATE CORP

 PRESS RELEASE
Free
VATE INNOVATE CORP

INNOVATE Corp. to Report First Quarter 2025 Results on May 6th

INNOVATE Corp. to Report First Quarter 2025 Results on May 6th NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the first quarter 2025 on Tuesday, May 6, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and...

April 16, 2025 1 EN
 PRESS RELEASE
Free
VATE INNOVATE CORP

INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results

INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results - Infrastructure: DBM Global fourth quarter revenue of $225.7 million -- Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) system received FDA approval to assess kidney function -- Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 - NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the fourth quarter. Financial Summary (in millions, exce...

March 31, 2025 1 EN
 PRESS RELEASE
Free
VATE INNOVATE CORP

INNOVATE Corp. to Report Fourth Quarter and Full Year 2024 Results on ...

INNOVATE Corp. to Report Fourth Quarter and Full Year 2024 Results on March 31st NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the fourth quarter and full year 2024 on Monday, March 31, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be br...

February 27, 2025 1 EN
 PRESS RELEASE
Free
VATE INNOVATE CORP

MediBeacon® Transdermal GFR System receives device approval in China

MediBeacon® Transdermal GFR System receives device approval in China Peer-reviewed articles on MediBeacon technology published Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.The Clinical Kidney Journal in February published MediBeacon study results on measured GFR (mGFR) using relmapirazin versus estimated GFR (eGFR) for the purpose of classifying patient Chronic Kidney Disease (CKD) stages.MediBeacon TGFR study results have been posted online in the February ahead of print section...

February 25, 2025 1 EN
 PRESS RELEASE
Free
VATE INNOVATE CORP

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kid...

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal functionThe transdermal GFR (tGFR) methodology has been designed to be effective across the adult population without input of age, weight, sex, gender, race, or ethnicityMore than 800 million people have Chronic Kidney Disease (CKD), one of the world’s leading causes of mortality worldwide, with associated deaths increasing over the past two decades1 NEW YORK, J...

January 17, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch